These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8717309)

  • 1. [Study on a predictive marker for evaluating the effectiveness of steroid therapy in IgA nephropathy-significance of extracapillary changes].
    Yamamoto S; Iesato K; Yoshida H; Hori J; Hasegawa R; Ohta Y; Akikusa B; Kondo Y
    Nihon Jinzo Gakkai Shi; 1996 Feb; 38(2):74-83. PubMed ID: 8717309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
    McIntyre CW; Fluck RJ; Lambie SH
    Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of methylprednisolone pulse therapy on progressive IgA nephropathy].
    Yoshimura M; Kida H; Saito Y; Takaeda M; Sugioka G
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):761-8. PubMed ID: 1770636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
    Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of steroid therapy in IgA nephropathy].
    Ohashi T; Shimokawahara H; Fukumoto M; Azuma K; Uchida Y; Tokuda Y; Ito H; Yasumoto Y; Yamashita W; Harada R
    Fukuoka Igaku Zasshi; 1992 May; 83(5):209-15. PubMed ID: 1612550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
    Uzu T; Harada T; Ko M; Yamato M; Takahara K; Yamauchi A
    Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy.
    Tsuruya K; Harada A; Hirakata H; Mitsuiki K; Johko T; Kondoh H; Takechi S; Fujishima M
    Clin Nephrol; 2000 Jan; 53(1):1-9. PubMed ID: 10661476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid therapy in IgA nephropathy: a prospective pilot study in moderate proteinuric cases.
    Kobayashi Y; Fujii K; Hiki Y; Tateno S
    Q J Med; 1986 Oct; 61(234):935-43. PubMed ID: 3628707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrotic range proteinuria--a good predictive index of disease in IgA nephropathy?
    Lai KN; Ho CP; Chan KW; Yan KW; Lai FM; Vallance-Owen J
    Q J Med; 1985 Oct; 57(222):677-88. PubMed ID: 4080957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of corticosteroid and warfarin therapy in IgA nephropathy with crescent formation: preliminary trial.
    Kanno Y; Witt M; Okada H; Nemoto H; Sugahara S; Nakamoto H; Suzuki H
    Clin Exp Nephrol; 2003 Mar; 7(1):48-51. PubMed ID: 14586743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial.
    Lai KN; Lai FM; Ho CP; Chan KW
    Clin Nephrol; 1986 Oct; 26(4):174-80. PubMed ID: 3536231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled, prospective trial of steroid treatment in IgA nephropathy: a limitation of low-dose prednisolone therapy.
    Katafuchi R; Ikeda K; Mizumasa T; Tanaka H; Ando T; Yanase T; Masutani K; Kubo M; Fujimi S
    Am J Kidney Dis; 2003 May; 41(5):972-83. PubMed ID: 12722031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal change disease versus IgA nephropathy.
    Jabur WL
    Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):116-9. PubMed ID: 19112229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological sub-analysis of a multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy versus steroid pulse monotherapy in patients with immunoglobulin A nephropathy.
    Katafuchi R; Kawamura T; Joh K; Hashiguchi A; Hisano S; Shimizu A; Miyazaki Y; Nagata M; Matsuo S;
    Clin Exp Nephrol; 2016 Apr; 20(2):244-52. PubMed ID: 26349433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgA nephropathy: heterogeneous clinical pictures and steroid therapy in progressive cases.
    Kobayashi Y; Hiki Y; Fujii K; Kurokawa A; Kamiyana M; Tateno S
    Semin Nephrol; 1987 Dec; 7(4):382-5. PubMed ID: 3445022
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical effectiveness of steroid pulse therapy combined with tonsillectomy in patients with immunoglobulin A nephropathy presenting glomerular haematuria and minimal proteinuria.
    Kawaguchi T; Ieiri N; Yamazaki S; Hayashino Y; Gillespie B; Miyazaki M; Taguma Y; Fukuhara S; Hotta O
    Nephrology (Carlton); 2010 Feb; 15(1):116-23. PubMed ID: 20377779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of vasculitic IgA nephropathy.
    Harper L; Ferreira MA; Howie AJ; Savage CO; Richards NT; Michael J; Adu D
    J Nephrol; 2000; 13(5):360-6. PubMed ID: 11063140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults.
    Maher ER; Sweny P; Chappel M; Varghese Z; Moorhead JF
    Nephrol Dial Transplant; 1988; 3(6):728-32. PubMed ID: 3147413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of extracapillary lesions (ECL) in progression of IgA nephropathy.
    Abe T; Kida H; Yoshimura M; Yokoyama H; Koshino Y; Tomosugi N; Hattori N
    Clin Nephrol; 1986 Jan; 25(1):37-41. PubMed ID: 3955907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of IgA nephropathy with crescents in kidney transplants.
    Mousson C; Charon-Barra C; Funes de la Vega M; Tanter Y; Justrabo E; Martin L; Rifle G
    Transplant Proc; 2007 Oct; 39(8):2595-6. PubMed ID: 17954186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.